What Does the Pharmacy NNN Shakeout Really Mean for Smart Investors in 2026?

Pharmacy NNN properties remain one of the most actively traded segments of the single-tenant net lease market — and in 2026, the sector is creating some of the most compelling yield opportunities available to passive investors. A period of footprint rationalization across the industry has thinned the supply of available assets and elevated cap rates on select properties, while CVS’s accelerating turnaround has reinforced the investment thesis for credit-quality buyers. For 1031 exchange investors, family offices, and accredited buyers seeking durable, landlord-free income, the pharmacy NNN sector deserves a fresh, data-driven look. Here is exactly what the current market is telling you.

Where Pharmacy NNN Cap Rates Stand in Q1 2026

Pharmacy NNN cap rates in 2026 span a notably wide range — and that spread is the opportunity. The widest part of the range rewards investors willing to do precise location-level underwriting rather than chasing brand names alone.

According to The Boulder Group’s Q1 2026 net lease research, Walgreens NNN properties are trading at cap rates ranging from 6.40% to 9.00% depending on remaining lease term, placing them among the highest-yielding opportunities in the entire net lease market for investors willing to accept some credit or operational nuance.
That spread — nearly 260 basis points wide — is not noise. It reflects two fundamentally different buyer pools: institutional capital targeting long-term, well-located Walgreens leases at the tight end, and yield-focused private investors accepting shorter remaining terms at the wide end.

The broader single-tenant NNN market saw cap rates decline one basis point to 6.80% in Q1 2026, according to The Boulder Group’s First Quarter Net Lease Research Report.
That compression in the broader index makes the 6.40%–9.00% pharmacy range look even more attractive for income-seekers by comparison.

CVS assets, backed by an S&P BBB+ rating, typically price toward the tighter end of the pharmacy spectrum.
Single-tenant NNN property supply declined 9.8% quarter-over-quarter in Q1 2026, driven by strong transaction volume in Q4 2025 and continued deal flow in the first quarter — and the market remains bifurcated, with investment-grade credit assets and long lease terms continuing to attract institutional buyers, 1031 exchange capital, and private investors.

CVS NNN Properties: The Investment-Grade Case in 2026

CVS is the pharmacy NNN sector’s most credit-stable tenant story right now. Its S&P BBB+ rating, combined with an active expansion posture, gives real estate investors a clear line of sight into rent coverage durability.

CVS Health reported fourth-quarter earnings and revenue that beat estimates and reaffirmed its 2026 profit guidance, signaling steady progress in the health-care giant’s turnaround plan.
That turnaround is being felt directly in the pharmacy segment:
CVS’s pharmacy and consumer wellness division posted $37.66 billion in sales for the fourth quarter, up 12.4% from the same period a year earlier, driven in part by higher prescription volume, including from the company’s acquisition of prescriptions from Rite Aid.

On the real estate side, CVS is growing again.
After years of contraction, CVS will open around 60 new stores in 2026, with plans to shutter just a few dozen — including 20 pharmacy-only stores, each around 3,000 square feet.
That new format signals where CVS’s capital is flowing: smaller, pharmacy-first footprints in high-density corridors. For existing NNN investors, this expansion dynamic reinforces renewal probability at proven, high-traffic locations.

CVS is maintaining its 2026 revenue guidance of at least $400 billion
— a figure that underscores the scale of the enterprise behind each lease.
As one Marcus & Millichap investment specialist noted in a March 2026 transaction, “regardless of broad changes at the corporate level for retail pharmacy companies, we are still seeing strong investor demand for the real estate they occupy across the United States.”

Recent transaction evidence confirms this.
In March 2026, Marcus & Millichap closed a net-leased CVS Pharmacy property in O’Fallon, Missouri for $2,975,000.

More than 15 years remain on the corporately guaranteed triple-net ground lease.
Deals like this — where corporate guaranty, long term, and suburban demographics align — are exactly the profile that 1031 exchange buyers and family offices are targeting. To see live deals structured along similar lines, Triple Net Direct aggregates active pharmacy NNN inventory from across the market.

Walgreens NNN Properties After the Sycamore Acquisition: What Investors Need to Know

Walgreens’ transition to private ownership under Sycamore Partners is the most consequential structural event in pharmacy NNN investing since the CVS-Aetna merger. Understanding what it means for lease security is essential before underwriting any Walgreens asset in 2026.

On August 28, 2025, Walgreens Boots Alliance was acquired by New York-based private equity firm Sycamore Partners in a $10 billion deal.

Walgreens now operates as a standalone private company focused on its pharmacy and retail operations.
For NNN investors, the critical data point is that existing leases — many of which are absolute NNN or long-term net structures — are unaffected by the ownership change. The corporate guaranty on leases remains in place at the operating company level.

Bloomberg reported that Walgreens decreased its planned closings to fewer than 100 locations in 2026
— a dramatically reduced pace compared to earlier announcements — and
Walgreens continues to operate more than 8,000 retail locations across the United States, Puerto Rico, and the U.S. Virgin Islands, serving approximately 8 million customers daily.

The market for well-located Walgreens NNN assets is active.
“Single tenant net leased pharmacy assets with substantial remaining lease term continue to attract strong investor interest,” according to Randy Blankstein, President of The Boulder Group.
Recent closed transactions back that up:
The Boulder Group closed the sale of a single-tenant net-leased Walgreens in Rochester Hills, Michigan for $3,825,000 — a 14,820-square-foot property built in 2005 within the Detroit MSA.

Blankstein noted that “net leased pharmacy properties with absolute NNN lease structures and long operating histories continue to attract local investor demand.”

Walgreens Lease Structures Worth Targeting

Not all Walgreens NNN leases are created equal. The deals that generate the most competitive bidding share a specific profile:

• Absolute NNN structure:
  Long-term absolute net leases with no landlord management or maintenance responsibilities — and when they include 5% rent increases every five years, they deliver meaningfully more cash flow than a traditional flat Walgreens lease.
• Monopoly-market positioning:
  Properties that serve as the only national pharmacy within a 12-mile radius reinforce the asset’s role as an essential healthcare destination
  — and strengthen renewal probability at lease expiration.
• Strong surrounding demographics:
  When surrounding demographics include average household income exceeding $150,000 within five miles and a population of over 185,000 residents within five miles
  , rent coverage risk drops substantially.

For a deeper framework on underwriting pharmacy NNN leases by location quality and lease term, read more NNN analysis on the Triple Net Direct blog.

How to Underwrite a Pharmacy NNN Property in the Current Market

Pharmacy NNN underwriting in 2026 rewards investors who look past the brand and focus on three specific variables: remaining lease term, escalation structure, and real estate quality. Get all three right and you have a durable income asset. Miss one and you’ve bought a story, not an investment.

Remaining Lease Term

Lease term drives cap rate more than any other single variable in the pharmacy NNN sector. The 6.40%–9.00% Walgreens range cited above is almost entirely explained by term. A Walgreens with 12+ years remaining will trade closer to 6.40%; a property with 4–6 years remaining will drift toward 8.00%–9.00% as fewer institutional buyers participate.
The net lease market remains bifurcated between investment-grade credit assets with long lease terms, which continue to attract institutional buyers, 1031 exchange capital, and private investors, and shorter-term or non-rated assets, which face wider spreads and more selective buyer engagement.

Rent Escalation Clauses

Many legacy pharmacy leases are flat — no rent bumps for the duration of the primary term. This was once the norm, but it compresses the real-dollar return over time. When evaluating any pharmacy NNN, prioritize leases with structured escalations.
According to The Boulder Group, net leased pharmacy properties backed by investment-grade tenants with proven operating histories continue to attract strong investor interest, particularly when positioned in established retail corridors within recognized MSAs.
Adding rent escalations to that profile makes the asset even more competitive at resale.

Real Estate Quality Factors

Pharmacy NNN buyers who focus on real estate fundamentals — not just tenant credit — build the most resilient portfolios. Key factors include:

• Corner visibility and drive-thru access — the physical features that anchor patient habit formation
• Traffic counts — properties on primary commercial thoroughfares with 30,000+ VPD commands the most repeat buyer demand at resale
• Affluent surrounding demographics — higher household incomes correlate with prescription adherence, OTC spend, and stable front-end sales
• Shadow-anchor positioning — co-tenancy with grocery, value retail, or quick-service generates cross-shopping traffic that protects store-level performance

Pharmacy NNN as a 1031 Exchange Target in 2026

Pharmacy NNN properties are among the most practical 1031 exchange destinations in the single-tenant market — especially for investors rolling out of active management. The lease structure does exactly what a 1031 buyer needs: passive income, no day-to-day responsibilities, and a corporate tenant that absorbs operating cost variability.

Nearly three quarters of commercial real estate investors plan to buy more assets in 2026 as prices stabilize and fundamentals improve
— and pharmacy NNN fits that acquisition posture well. The combination of elevated cap rates on select Walgreens assets and the credit stability of CVS creates a rare window where yield and quality can coexist within the same sector.

For 1031 exchange buyers specifically, the deal profile that closes fastest tends to share these characteristics: corporately guaranteed lease, minimum 10 years remaining term, absolute NNN structure, and a price point below $5 million where private-buyer competition is deepest. The March 2026 CVS sale in O’Fallon —
procured for a local Missouri 1031 exchange buyer
— is exactly representative of where that capital is landing. To connect with a specialist advisor who focuses on pharmacy NNN deal sourcing, Triple Net Direct can facilitate that introduction.

Frequently Asked Questions

What are typical cap rates for pharmacy NNN properties in 2026?

Walgreens NNN properties are ranging from 6.40% to 9.00% in Q1 2026 depending on remaining lease term and location quality, according to The Boulder Group. CVS assets, backed by an S&P BBB+ rating, typically price at the tighter end of that range. The broadest cap rates reflect shorter remaining lease terms rather than a shift in tenant credit fundamentals.

Is CVS still an investment-grade NNN tenant in 2026?

Yes. CVS Health maintains an S&P investment-grade rating of BBB+ and is actively expanding its store count in 2026 with approximately 60 new openings planned. Its pharmacy and consumer wellness division posted $37.66 billion in Q4 2025 revenue — up 12.4% year-over-year — which reinforces the rent coverage story behind existing NNN leases.

What does Walgreens being taken private mean for NNN lease investors?

Walgreens was acquired by private equity firm Sycamore Partners in a $10 billion deal that closed in August 2025. Existing NNN leases remain in force at the operating company level. Sycamore has signaled a focus on pharmacy and retail operations, and the chain has significantly reduced its planned store closings for 2026 to fewer than 100 locations nationwide.

How does remaining lease term affect pharmacy NNN pricing?

Remaining lease term is the dominant pricing variable in pharmacy NNN. Properties with 12+ years of term trade at the tightest cap rates and attract the widest buyer pool — including institutions and 1031 exchange capital. Assets with under six years of primary term remaining face wider spreads and more selective buyer engagement, which can translate into longer marketing periods.

Are pharmacy NNN properties good for 1031 exchanges?

Pharmacy NNN properties are among the most practical 1031 exchange destinations in net lease. The absolute NNN structure eliminates landlord responsibilities, the corporate tenant guaranty provides income certainty, and price points below $5 million offer broad buyer liquidity at resale. CVS and Walgreens properties with 10+ years of term are particularly active 1031 exchange targets in 2026.

What lease structure should I look for in a pharmacy NNN property?

The strongest pharmacy NNN leases are absolute NNN structures with no landlord responsibility for taxes, insurance, or maintenance. Properties that include rent escalation clauses — ideally 5% increases every five years or CPI-based bumps — outperform flat-rent leases over full hold periods. A corporate guaranty from the parent entity, rather than a franchisee, is standard for CVS and Walgreens deals.

Bottom Line

The pharmacy NNN sector in 2026 is a precision investor’s market. CVS’s investment-grade credit, expanding store count, and accelerating revenue make it the sector’s anchor credit play. Walgreens, operating under focused private ownership, is stabilizing its footprint and continuing to generate active transaction volume at yield levels that meaningfully exceed the broader NNN market average. The investors who win in this sector underwrite location first, lease term second, and brand third. View available NNN pharmacy deals on Triple Net Direct and position accordingly.

Sources

• CVS Tops Quarterly Estimates, Reaffirms Profit Outlook as Turnaround Plan Takes Effect — CNBC
• CVS to Increase Retail Footprint After 4 Years of Shrinking Its Store Count — Bisnow
• Q1 2026 Net Lease Research Report — The Boulder Group
• Net Leased CVS Pharmacy Sold in Virginia — The Boulder Group
• Net Leased Walgreens Sold — Detroit MSA — The Boulder Group
• Marcus & Millichap Brokers $2.98M Sale of CVS Property in O’Fallon, Missouri — Marcus & Millichap
• Walgreens to Go Private in Roughly $10 Billion Deal with Sycamore Partners — CNBC
• U.S. Cap Rate Survey H2 2025 — CBRE